• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT LABORATORIES ARCHITECT STAT TROPONIN-I; IMMUNOASSAY METHOD, TROPONIN SUBUNIT Back to Search Results
Catalog Number 02K41-27
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/26/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
This issue was previously reported under mdr number 3016438761-2026-00083-01 under a different suspect device.Data and information provided by the customer were reviewed and support the complaint issue.Review of tracking and trending data identified an increase in complaints for the architect stat troponin-i assay as well as an increase in complaint activity for reagent lot 85694un25.However, historical performance of the architect stat troponin-i assay lot 85694un25 was evaluated using worldwide data and no unusual reagent lot performance was identified.The patient median data (divided into 3 groups) and cal f rlu mean were analyzed and compared to an established control limit.This evaluation indicated that all three levels of the patient medians and the cal f rlu mean for the lot for lot 85694un25 are within the established limits.A device history record review was performed for lot 85694 un25, which did not show any potential non-conformances, deviations, or non-conformances.Labeling was reviewed and found to adequately address the customer's issue.Based on the investigation, no systemic issue or deficiency of the architect stat troponin-i reagent lot 85694un25 was identified.
 
Event or Problem Description
The customer observed imprecise architect stat troponin-i results for two patients.The following data was provided: sid (b)(6) 73-year-old male processed on (b)(6) 2026: initial result processed on architect serial number (b)(6) = 30 repeat 30.Sample was then processed on architect serial number (b)(6) results = 66 and 50.Sid (b)(6) 55-year-old male processed on (b)(6) 2026: initial run on (b)(6) = 643(not reported) repeat = <20.Repeated on (b)(6) = <20 redraw from same patient = <20 on both (b)(6).Customer¿s reference range = 0-30 ng/l no impact to patient management was reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT STAT TROPONIN-I
Common Device Name
IMMUNOASSAY METHOD, TROPONIN SUBUNIT
Manufacturer (Section D)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064
Manufacturer (Section G)
ABBOTT LABORATORIES
100 abbott park road
abbott park IL 60064
Manufacturer Contact
nicole jenne
max-planck-ring 2
post market surveillance
wiesbaden 65205
GM   65205
6122582960
MDR Report Key25008341
Report Number1415939-2026-00011
Device Sequence Number9757070
Product Code MMI
UDI-Device Identifier00380740048525
UDI-Public(01)00380740048525(17)260831(10)85694UN25
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K041192
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date (Section B) 04/27/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/31/2026
Device Catalogue Number02K41-27
Device Lot Number85694UN25
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/07/2026
Initial Report FDA Received Date04/27/2026
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/11/2025
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ARC I1000SR INTGR, 01L86-40, (B)(6).
Patient SexUnknown
-
-